EPCAM and neoplasm: Since there were some reported EpCAM CARs in other tumor models [20–30], we constructed a reported EpCAM CAR composed of a fully human scFv derived from a reported anti-EpCAM monoclonal antibody named UBS54 with a Y6F mutation [27, 46] and evaluated its anti-tumor efficacy together with our EpCAM CAR.